O
Singular Genomics Systems, Inc.
OMIC US
OMIC USSingular Genomics Systems, Inc.
United States Composite0.32
USD
-0.01
(-1.96%)
Next Earnings
August 7
Held by Insiders
14.01%
Held by Institutions
47.17%
Short % of Float
0.90%
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mr. Andrew Spaventa
- Full Time Employees
- 255
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Address
- 3010 Science Park Road San Diego CA United States 92121
- IPO Date
- May 27, 2021
- Website
- www.singulargenomics.com
- Business
- Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.